Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.
CHICAGO, Jan. 19, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today announced it has reached a definitive [...]
Bardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer
Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory [...]
Bardy Diagnostics™ Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team
Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies [...]
Bardy Diagnostics™ Selected as Winner of the MedTech Breakthrough Award For Best New Diagnostic Technology
MedTech Breakthrough Announces Winners of the Annual MedTech Breakthrough Awards Program MedTech [...]
Bardy Diagnostics Earns Acclaim from Frost & Sullivan for Its Groundbreaking Carnation Ambulatory Monitor™ Patch for Arrhythmia Monitoring
Based on its recent analysis of the North American remote cardiac monitoring [...]
Bardy Diagnostics™ Announces $35.5M in Series B Funding Round
SEATTLE, April 16, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading [...]
Bardy Diagnostics™ Achieves Milestone of 40,000 Patients Monitored by the Carnation Ambulatory Monitor
Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies [...]
Bardy Diagnostics™ Selected As Winner Of The Fierce Innovation Life Sciences Award
SEATTLE, Dec. 17, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading [...]
Bardy Diagnostics™ Selected as a Winner of the Children’s National Pediatric Medical Device Innovation Competition
SEATTLE, Sept. 26, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading [...]